C07K 16/1214
Pseudomonadaceae
Official title: Pseudomonadaceae (F)
C07K16/1214 (Pseudomonadaceae) appears on 161 US grants and 211 published applications in this corpus.
Search patents in C07K- Granted patents
- 161
- Published applications
- 211
- Assignees
- 152
- Inventors
- 427
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 5 |
| 2004 | 2 | 5 |
| 2005 | 2 | 5 |
| 2006 | 3 | 5 |
| 2007 | 4 | 6 |
| 2008 | 3 | 2 |
| 2009 | 3 | 13 |
| 2010 | 5 | 7 |
| 2011 | 7 | 9 |
| 2012 | 7 | 9 |
| 2013 | 5 | 14 |
| 2014 | 4 | 8 |
| 2015 | 9 | 14 |
| 2016 | 6 | 16 |
| 2017 | 3 | 9 |
| 2018 | 9 | 5 |
| 2019 | 5 | 11 |
| 2020 | 8 | 14 |
| 2021 | 6 | 7 |
| 2022 | 3 | 13 |
| 2023 | 2 | 9 |
| 2024 | 9 | 15 |
| 2025 | 7 | 5 |
| 2026 | 6 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Monoclonal antibody and vaccine targeting filamentous bacteriophage23 Jun 2026US 12,661,411 B2Inimmune Corporation
- Vaccines targeting Pseudomonas aeruginosa21 Apr 2026US 12,606,597 B2Evaxion Biotech A/S
- Antibodies specifically recognizing Pseudomonas Psl and uses thereof10 Mar 2026US 12,570,727 B2Beijing Solobio Genetechnology Company Ltd.
- Combinations of antibodies and bispecific antibodies comprising antigen-binding specifically recognizing Pseudomonas PcrV and Psl10 Mar 2026US 12,570,728 B2Beijing Solobio Genetechnology Company Ltd.
- Multivalent DNA antibody constructs and use thereof24 Feb 2026US 12,559,547 B2The Wistar Institute of Anatomy and Biology
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
- Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof2 Jul 2026US 2026/0184768 A1Regeneron Pharmaceuticals, Inc.
- Compositions and methods for using bispecific antibodies to bind complement and a target antigen2 Apr 2026US 2026/0092102 A1Regeneron Pharmaceuticals, Inc.
- Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasis18 Dec 2025US 2025/0382356 A1AstraZeneca AB
Most cited
By later US patents
- Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria112US 4,918,163 APfizer Inc. · 1990
- Human monoclonal antibody, and its production and use75US 5,196,337 ASumitomo Chemical Company, Limited · 1993
- Methods and compositions for the direct concentrated delivery of passive immunity67US 5,530,102 A1996
- Method and compositions for the direct concentrated delivery of passive immunity45US 5,505,945 AMedical Sciences Research Institute · 1996
- Composition of intravenous immune globulin41US 4,482,483 AArmour Pharmceutical Company · 1984